D. Anderson Cancer Center and a member of the faculty of the University of Texas Graduate School of Biomedical Sciences. His research is directed at understanding the critical genetic events that lead to the development of leukemia and to the discovery of novel therapeutic approaches through molecular strategies. Clinically, Dr. Zweidler-McKay specializes in treating children who have particularly difficult or relapsed forms of leukemia and lymphoma. He is certified by the American Board of Pediatrics and is a member of the American Society of Hematology, the American Society of Pediatric Hematology and Oncology, the Harris County Medical Society, and the Texas Medical Society. Dr. Zweidler-McKay earned a PhD in molecular biology and genetics and an MD from Temple University.